Antimycobacterial activity of natural products and synthetic agents: Pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis

被引:67
|
作者
Ganihigama, Dakshina U. [1 ]
Sureram, Sanya [2 ]
Sangher, Sasithorn [2 ]
Hongmanee, Poonpilas [3 ]
Aree, Thammarat [4 ]
Mahidol, Chulabhorn [1 ,2 ]
Ruchirawat, Somsak [1 ,2 ,5 ]
Kittakoop, Prasat [1 ,2 ,5 ]
机构
[1] Chulabhorn Grad Inst, Chem Biol Program, Bangkok 10210, Thailand
[2] Chulabhorn Res Inst, Bangkok 10210, Thailand
[3] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Microbiol,Dept Pathol, Bangkok 10400, Thailand
[4] Chulalongkorn Univ, Fac Sci, Dept Chem, Bangkok 10330, Thailand
[5] Ctr Excellence Environm Hlth & Toxicol EHT, CHE, Minist Educ, Bangkok, Thailand
关键词
Antimycobacterial activity; Mycobacterium tuberculosis; Multidrug resistant tuberculosis; Natural product; Antimycobacterial compound; Microwave-assisted synthesis; SECONDARY METABOLITES; ALKALOIDS; ANALOGS; DESIGN; PLANTS; FUNGI;
D O I
10.1016/j.ejmech.2014.10.026
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Various classes of natural products and synthetic compounds were tested against reference strains and clinical multidrug resistant isolates of Mycobacterium tuberculosis. Vermelhotin (19), a natural tetramic acid from fungi, was the most active toward clinical MDR TB isolates (MIC 1.5-12.5 mu g/mL). Synthetic compounds (i.e. benzoxazocines, coumarins, chromenes, and pyrrolodiquinoline derivatives) were prepared by green chemistry approaches. Under microwave irradiation, a one-pot synthesis of pyrrolodiquinoline 85 was achieved by homocoupling of 1-methylquinolinium iodide; the structure of 85 was confirmed by single-crystal X-ray analysis. Compound 85 and its derivative 86 exhibited potent antitubercular activity (MIC 0.3-6.2 mu g/mL) against clinical MDR TB isolates, and they displayed weak cytotoxicity toward normal cell line. The scaffold of 85 and 86 is potential for antimycobacterial activity. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [31] In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates
    Zhang, Zhijian
    Li, Tianzhi
    Qu, Geping
    Pang, Yu
    Zhao, Yanlin
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (01) : 71 - 75
  • [32] Anti-tubercular and antioxidant activities of C-glycosyl carbonic anhydrase inhibitors: towards the development of novel chemotherapeutic agents against Mycobacterium tuberculosis
    Zaro, Maria J.
    Bortolotti, Ana
    Riafrecha, Leonardo E.
    Concellon, Analia
    Morbidoni, Hector R.
    Colinas, Pedro A.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (06) : 1726 - 1730
  • [33] Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates
    Gupta, Renu
    Thakur, Bandana
    Singh, Pushpendra
    Singh, H. B.
    Sharma, V. D.
    Katoch, V. M.
    Chauhan, S. V. S.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2010, 131 (06) : 809 - 813
  • [34] In Vitro Activity of Linezolid against Clinical Isolates of Mycobacterium tuberculosis, including Multidrug-Resistant and Extensively Drug-Resistant Strains from Beijing, China
    Yang, Caie
    Lei, Hong
    Wang, Di
    Meng, Xianghong
    He, Jufang
    Tong, Aihua
    Zhu, Lei
    Jiang, Ying
    Dong, Mei
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2012, 65 (03) : 240 - 242
  • [35] Antitubercular Activity of Disulfiram, an Antialcoholism Drug, against Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Isolates
    Horita, Yasuhiro
    Takii, Takemasa
    Yagi, Tetsuya
    Ogawa, Kenji
    Fujiwara, Nagatoshi
    Inagaki, Emi
    Kremer, Laurent
    Sato, Yasuo
    Kuroishi, Ryuji
    Lee, YooSa
    Makino, Toshiaki
    Mizukami, Hajime
    Hasegawa, Tomohiro
    Yamamoto, Ryuji
    Onozaki, Kikuo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4140 - 4145
  • [36] Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo
    Zhao, Weijie
    Zheng, Meiqin
    Wang, Bin
    Mu, Xiaopan
    Li, Peng
    Fu, Lei
    Liu, Shuo
    Guo, Zhenyong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 52 : 23 - 28
  • [37] Design and Synthesis of 2-Amino-thiophene-proline-conjugates and Their Anti-tubercular Activity against Mycobacterium Tuberculosis H37Ra
    Baravkar, Sachin B.
    Wagh, Mahendra A.
    Nawale, Laxman U.
    Choudhari, Amit S.
    Bhansali, Sujit
    Sarkar, Dhiman
    Sanjayan, Gangadhar J.
    CHEMISTRYSELECT, 2019, 4 (09): : 2851 - 2857
  • [38] Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates
    Bakula, Zofia
    Napiorkowska, Agnieszka
    Kaminski, Michal
    Augustynowicz-Kopec, Ewa
    Zwolska, Zofia
    Bielecki, Jacek
    Jagielski, Tomasz
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (03) : 439 - 444
  • [39] Effects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates
    Ferraz-Carvalho, Rafaela S.
    Pereira, Marcela A.
    Linhares, Leonardo A.
    Lira-Nogueira, Mariane C. B.
    Cavalcanti, Isabella M. F.
    Santos-Magalhaes, Nereide S.
    Montenegro, Lilian M. L.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2016, 111 (05): : 330 - 334
  • [40] Synthesis, pharmacokinetic and molecular docking studies of new benzohydrazide derivatives possessing anti-tubercular activity against Mycobacterium tuberculosis H37Rv
    Lalavani, Nilam H.
    Gandhi, Himani R.
    Bhensdadia, Krishna A.
    Patel, Rajesh K.
    Baluja, Shipra H.
    Journal of Molecular Structure, 2022, 1250